Cote d’Ivoire

A snapshot of PrEP scale-up, registration and resources for Cote D'Ivoire.

  • 4,000 - 4,500
    Estimated Cumulative Number of People Initiating PrEP

    Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

  • 7,465
    PEPFAR PrEP Target in COP 2022

    Targets are set by PEPFAR country teams on an annual basis. Targets do not indicate funding is available for PrEP.

Data Updated: April 11, 2022

Drug Registration Status

  • Gilead's Truvada (TDF/FTC) registration
    Approved
  • Generic versions of TDF/FTC for prevention
    Under review
  • Viiv’s Apretude (CAB for PrEP) Registration
    Not approved
  • IPM’s Dapivirine Ring Registration
    Not approved

Types of Projects

  • Large-scale implementation initiative — funded/implementer involvement and investment in some or all steps related to comprehensive introduction that may or may not use government clinics as the primary service delivery point – e.g., Kenya’s Jilinde program.
  • Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.

Research, Demonstration and Implementation Projects

Funding

  • ANRS
  • PEPFAR
  • Expertise France

Resources for Cote d’Ivoire